Literature DB >> 26687128

Spontaneous inward currents reflecting oscillatory activation of Na⁺/Ca²⁺ exchangers in human embryonic stem cell-derived cardiomyocytes.

Seong Woo Choi1, Hyang-Ae Lee1,2, Sung-Hwan Moon3, Soon-Jung Park3, Hae Jin Kim1,4, Ki-Suk Kim1,2, Yin Hua Zhang1,4, Jae Boum Youm5, Sung Joon Kim6,7.   

Abstract

Na(+)/Ca(2+) exchanger current (INCX) triggered by spontaneous Ca(2+) release from sarcoplasmic reticulum (SR) has been suggested as one of the cardiac pacemaker mechanisms ("Ca(2+) clock model"). In human embryonic stem cell-derived cardiomyocytes (hESC-CMs) showing spontaneous action potentials (APs), we found that substantial population (35 %) showed regular oscillation of inward currents (SICs) in nystatin-perforated voltage clamp between -40 and 40 mV (-80 ± 10.6 pA, at -20 mV). SICs were similarly observed between nodal, atrial, and ventricular hESC-CMs. Oscillations of [Ca(2+)]i synchronized with SICs were observed under voltage clamp. SICs were eliminated by lowering [Ca(2+)]e, L-type Ca(2+) channel (VOCCL) blocker (nifedipine, 10 µM), ryanodine receptor (RyR) agonist (caffeine, 10 mM), or NCX inhibitor (1 µM SN-6 and 10 µM KB-R7943). Plasma membrane expression of NCX1 was confirmed using immunofluorescence confocal microcopy. Both caffeine and SN-6 slowed the pacemaker potential but did not abolish the AP generation. The inhibitors of funny current (3 µM ivabradine) or voltage-gated K(+) channel currents (1 µM E4031 and 10 µM chromanol-293B) also did not abolish but slowed the pacemaker potential. In a computational model of cardiac pacemaker by Maltsev and Lakatta (2009), after modifying the spatial distribution of RyR, VOCCL, and NCX by using our multiparameter adjust algorithm, we could successfully reproduce spontaneous SR Ca(2+) release and SICs under voltage clamp. It was proposed that, under the membrane depolarization activating VOCCL, oscillatory Ca(2+) releases via RyR induce sharp increases in subsarcolemmal [Ca(2+)]i and inward INCX (SICs). Since the hESC-CMs without SICs still showed spontaneous APs, the putative "Ca(2+) clock" would provide a redundant pacemaker or augmenting mechanism in hESC-CMs.

Entities:  

Keywords:  Ca2+ release; Embryonic stem cell; Heart; NCX; Pacemaker current

Mesh:

Substances:

Year:  2015        PMID: 26687128     DOI: 10.1007/s00424-015-1769-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  34 in total

Review 1.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.

Authors:  Christine L Mummery; Jianhua Zhang; Elizabeth S Ng; David A Elliott; Andrew G Elefanty; Timothy J Kamp
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

Review 2.  A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker.

Authors:  Edward G Lakatta; Victor A Maltsev; Tatiana M Vinogradova
Journal:  Circ Res       Date:  2010-03-05       Impact factor: 17.367

Review 3.  Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Xiulan Yang; Lil Pabon; Charles E Murry
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

4.  Intracellular calcium and Na+-Ca2+ exchange current in isolated toad pacemaker cells.

Authors:  Y K Ju; D G Allen
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

5.  Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes.

Authors:  Ji-Dong Fu; Peng Jiang; Stephanie Rushing; Jing Liu; Nipavan Chiamvimonvat; Ronald A Li
Journal:  Stem Cells Dev       Date:  2010-06       Impact factor: 3.272

6.  Three-dimensional distribution of cardiac Na+-Ca2+ exchanger and ryanodine receptor during development.

Authors:  Pauline Dan; Eric Lin; Jingbo Huang; Perveen Biln; Glen F Tibbits
Journal:  Biophys J       Date:  2007-06-08       Impact factor: 4.033

7.  The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.

Authors:  Sung-Hwan Moon; Sun-Woong Kang; Soon-Jung Park; Daekyeong Bae; Sung Joon Kim; Hyang-Ae Lee; Kyung Soo Kim; Ki-Sung Hong; Jong Soo Kim; Jeong Tae Do; Ki Hyun Byun; Hyung-Min Chung
Journal:  Biomaterials       Date:  2013-03-05       Impact factor: 12.479

8.  Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells.

Authors:  Laurie B Hazeltine; Chelsey S Simmons; Max R Salick; Xiaojun Lian; Mehmet G Badur; Wenqing Han; Stephanie M Delgado; Tetsuro Wakatsuki; Wendy C Crone; Beth L Pruitt; Sean P Palecek
Journal:  Int J Cell Biol       Date:  2012-05-09

9.  Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes.

Authors:  Michelangelo Paci; Laura Sartiani; Martina Del Lungo; Marisa Jaconi; Alessandro Mugelli; Elisabetta Cerbai; Stefano Severi
Journal:  Biomed Eng Online       Date:  2012-08-28       Impact factor: 2.819

10.  Intracellular Ca2+ oscillations, a potential pacemaking mechanism in early embryonic heart cells.

Authors:  Philipp Sasse; Jianbao Zhang; Lars Cleemann; Martin Morad; Juergen Hescheler; Bernd K Fleischmann
Journal:  J Gen Physiol       Date:  2007-08       Impact factor: 4.086

View more
  3 in total

1.  Protein Kinase 2β Is Expressed in Neural Crest-Derived Urinary Pacemaker Cells and Required for Pyeloureteric Contraction.

Authors:  Samir M Iskander; Meghan M Feeney; Kirby Yee; Norman D Rosenblum
Journal:  J Am Soc Nephrol       Date:  2018-02-07       Impact factor: 10.121

Review 2.  Electrophysiological properties and calcium handling of embryonic stem cell-derived cardiomyocytes.

Authors:  Jae Boum Youm
Journal:  Integr Med Res       Date:  2016-01-07

Review 3.  The Cardiac Pacemaker Story-Fundamental Role of the Na+/Ca2+ Exchanger in Spontaneous Automaticity.

Authors:  Zsófia Kohajda; Axel Loewe; Noémi Tóth; András Varró; Norbert Nagy
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.